article · American Journal of Veterinary Research
Objective: Campylobacter jejuni is a leading zoonotic pathogen, with broiler chickens as a primary reservoir and source of human campylobacteriosis. This study investigated prevalence, phenotypic and genotypic antimicrobial resistance, and virulence genes in C jejuni from broiler chicken samples at Egyptian slaughterhouses. Methods: 100 samples were randomly taken from slaughterhouses, comprising drippings (n = 50), neck skin (25), and cecal swabs (25). Campylobacter isolates were identified by 23S rRNA and mapA gene. Results: C jejuni was isolated from 18 of 100 samples (18%). The C jejuni isolates exhibited resistance against tetracycline (TE; 100%), amoxicillin (AMX; 83.3%), sulphamethoxazole-trimethoprim (SXT; 72.2%), and erythromycin (E; 66.7%). Meanwhile, the recovered isolates were found to be sensitive to meropenem (100%). There were 5 phenotypic resistance profiles: AMX, SXT, E, and TE (44.4%); AMX, E, and TE (22.2%); AMX, TE, and SXT (16.7%); TE and SXT (11.1%); and TE (5.6%). C jejuni strains harbored the tet(O) (100%) and blaOXA-61 (83.3%) genes. There were 2 genotypic resistance profiles, blaOXA-61 and tet(O) (83.3%) and tetO (16.7%). C jejuni harbored cadF, dnaJ, flaA, and cdtB virulence genes with a prevalence of 100%, 100%, 44.4%, and 22.2%, respectively. There were 3 virulence profiles: cadF+, dnaJ+, flaA+, and cdtB+ (22.2%); cadF+, dnaJ+, flaA+, and cdtB- (27.8%); and cadF+, dnaJ+, flaA-, and cdtB- (50%). Conclusions: Our findings demonstrate that multidrug-resistant C jejuni harboring key virulence/resistance genes in broilers is a significant concern for both public health and poultry production. Clinical Relevance: The detection of multidrug-resistant, virulent C jejuni underscores a substantial risk of carcass contamination and foodborne campylobacteriosis in humans.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.2460/ajvr.26.02.0056
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.